Phibro Animal Health [PAHC] vs Zoetis [ZTS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 21 vital metrics comparison: Phibro Animal Health Corporation wins in 9 metrics, Zoetis Inc. wins in 12 metrics, with 0 ties. Zoetis Inc. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Phibro Animal Health Corporation | Zoetis Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 24.20 | 19.58 | Zoetis Inc. |
| Price-to-Book Ratio | 6.67 | 15.04 | Phibro Animal Health Corporation |
| Debt-to-Equity Ratio | 233.04 | 279.59 | Phibro Animal Health Corporation |
| PEG Ratio | 0.03 | 2.81 | Phibro Animal Health Corporation |
| EV/EBITDA | 12.75 | 13.96 | Phibro Animal Health Corporation |
| Profit Margin (TTM) | 6.29% | 28.24% | Zoetis Inc. |
| Operating Margin (TTM) | 14.71% | 34.69% | Zoetis Inc. |
| EBITDA Margin (TTM) | 14.71% | 34.69% | Zoetis Inc. |
| Return on Equity | 31.80% | 65.99% | Zoetis Inc. |
| Return on Assets (TTM) | 8.34% | 15.26% | Zoetis Inc. |
| Free Cash Flow (TTM) | $41.83M | $2.28B | Zoetis Inc. |
| Dividend Yield | 1.20% | 1.21% | Zoetis Inc. |
| 1-Year Return | 31.76% | -51.58% | Phibro Animal Health Corporation |
| Price-to-Sales Ratio (TTM) | 1.51 | 5.26 | Phibro Animal Health Corporation |
| Enterprise Value | $2.92B | $56.75B | Zoetis Inc. |
| EV/Revenue Ratio | 1.99 | 6.00 | Phibro Animal Health Corporation |
| Gross Profit Margin (TTM) | 35.48% | 70.17% | Zoetis Inc. |
| Revenue per Share (TTM) | $36 | $21 | Phibro Animal Health Corporation |
| Earnings per Share (Diluted) | $2.26 | $6.02 | Zoetis Inc. |
| Beta (Stock Volatility) | 0.69 | 0.97 | Phibro Animal Health Corporation |
| Short % of Float | 6.77% | 4.06% | Zoetis Inc. |
Phibro Animal Health Corporation vs Zoetis Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Phibro Animal Health Corporation | 2.38% | 1.64% | -6.08% | -36.92% | -20.63% | -13.46% |
| Zoetis Inc. | 1.51% | 0.16% | 3.42% | -31.08% | -32.94% | -36.81% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Phibro Animal Health Corporation | 31.76% | 128.15% | 7.32% | 67.00% | 85.47% | 85.47% |
| Zoetis Inc. | -51.58% | -53.40% | -57.08% | 71.34% | 156.59% | 156.59% |
Performance & Financial Health Analysis: Phibro Animal Health Corporation vs Zoetis Inc.
| Metric | PAHC | ZTS |
|---|---|---|
| Market Information | ||
| Market Cap | $2.22B | $49.75B |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 233,669 | 2,727,710 |
| 90 Day Avg. Volume | 289,930 | 3,835,940 |
| Last Close | $32.28 | $167.10 |
| 52 Week Range | $23.57 - $60.08 | $139.70 - $200.33 |
| % from 52W High | -46.27% | -16.59% |
| All-Time High | $60.08 (Apr 13, 2026) | $249.27 (Dec 27, 2021) |
| % from All-Time High | -46.27% | -32.96% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.21% | 0.03% |
| Quarterly Earnings Growth | 7.62% | 0.04% |
| Financial Health | ||
| Profit Margin (TTM) | 0.06% | 0.28% |
| Operating Margin (TTM) | 0.15% | 0.35% |
| Return on Equity (TTM) | 0.32% | 0.66% |
| Debt to Equity (MRQ) | 233.04 | 279.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $8.20 | $7.84 |
| Cash per Share (MRQ) | $1.85 | $5.48 |
| Operating Cash Flow (TTM) | $93.08M | $2.90B |
| Levered Free Cash Flow (TTM) | $21.79M | $1.79B |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.20% | 1.21% |
| Last 12-Month Dividend | $0.60 | $2.03 |
Valuation & Enterprise Metrics Analysis: Phibro Animal Health Corporation vs Zoetis Inc.
| Metric | PAHC (Apr 24, 2026) | ZTS (Apr 13, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 24.20 | 19.58 |
| Forward P/E | 16.14 | 15.61 |
| PEG Ratio | 0.03 | 2.81 |
| Price to Sales (TTM) | 1.51 | 5.26 |
| Price to Book (MRQ) | 6.67 | 15.04 |
| Market Capitalization | ||
| Market Capitalization | $2.22B | $49.75B |
| Enterprise Value | $2.92B | $56.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.99 | 6.00 |
| Enterprise to EBITDA | 12.75 | 13.96 |
| Risk & Other Metrics | ||
| Beta | 0.69 | 0.97 |
| Book Value per Share (MRQ) | $8.20 | $7.84 |
Financial Statements Comparison: Phibro Animal Health Corporation vs Zoetis Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | PAHC (2025) | ZTS (2025) |
|---|---|---|
| Revenue/Sales | 1.30B | 9.47B |
| Cost of Goods Sold | 896.27M | 2.67B |
| COGS % of Revenue | 69.1% | 28.2% |
| Gross Profit | 399.94M | 6.80B |
| Gross Margin | 30.9% | 71.8% |
| Research & Development | N/A | 698.00M |
| Operating Income (EBIT) | 110.47M | 3.60B |
| Operating Margin | 8.5% | 38.0% |
| EBITDA | 154.72M | 4.17B |
| EBITDA Margin | 11.9% | 44.1% |
| Pre-Tax Income | 67.99M | 3.36B |
| Pre-Tax Income % of Revenue | 5.2% | 35.5% |
| Income Tax | 19.73M | 687.00M |
| Income Tax % of Revenue | 1.5% | 7.3% |
| Net Income (Profit) | 48.26M | 2.67B |
| Profit Margin | 3.7% | 28.2% |
Balance Sheet & Liquidity Metrics
| Metric | PAHC (2025) | ZTS (2025) |
|---|---|---|
| Cash & Equivalents | 68.04M | 2.31B |
| Total Current Assets | 810.61M | 6.77B |
| Total Current Assets % of Revenue | 62.5% | 71.5% |
| Total Current Liabilities | 293.47M | 2.24B |
| Total Current Liabilities % of Revenue | 22.6% | 23.6% |
| Long-Term Debt | 736.18M | 9.24B |
| Long-Term Debt % of Revenue | 56.8% | 97.6% |
| Total Shareholders Equity | 285.68M | 3.33B |
| Retained Earnings | 272.70M | 13.74B |
| Retained Earnings % of Revenue | 21.0% | 145.2% |
| Property, Plant & Equipment | 41.34M | 288.00M |
Cash Flow Statement Comparison
| Metric | PAHC (2025) | ZTS (2025) |
|---|---|---|
| Operating Cash Flow | 27.04M | 2.78B |
| Operating Cash Flow % of Revenue | 2.1% | 29.3% |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | 41.83M | 2.28B |
| FCF Margin | 3.2% | 24.1% |
| Debt Repayment | -946.01M | -1.35B |
| Common Stock Repurchase | N/A | -3.24B |
Short Interest & Institutional Ownership Analysis
| Metric | PAHC | ZTS |
|---|---|---|
| Shares Short | 1.17M | 15.12M |
| Short Ratio | 3.76 | 3.60 |
| Short % of Float | 6.77% | 4.06% |
| Shares Outstanding | 40.53M | 424.93M |
| Float Shares | 20.46M | 421.29M |
| % Held by Insiders | 0.74% | 0.15% |
| % Held by Institutions | 96.81% | 101.50% |
| % Held by Public | 2.45% | -1.65% |
Dividend Analysis & Yield Comparison: Phibro Animal Health Corporation vs Zoetis Inc.
| Metric | PAHC | ZTS |
|---|---|---|
| Last 12-Month Dividend | $0.60 | $2.03 |
| Last 12-Month Dividend Yield | 1.20% | 1.21% |
| 3-Year Avg Annual Dividend | $0.52 | $1.80 |
| 3-Year Avg Dividend Yield | 0.65% | 0.29% |
| 3-Year Total Dividends | $1.56 | $5.39 |
| Ex-Dividend Date | Mar 04, 2026 | Jan 20, 2026 |